Moderna wins panel backing for COVID-19 vaccine

 

• Vaccines and Related Biological Products Advisory Committee of the FDA has endorsed the COVID-19 vaccine candidate from Moderna (NASDAQ:MRNA), STAT News reports.
• The question of ‘based on the totality of scientific evidence available, do the benefits of the Moderna Covid-19 vaccine outweigh its risks for use in individuals 18 years of age and older?’ has received 20 votes in favor with one abstention.
• Though FDA is not bound by the endorsement, the regulator often follows the recommendation, which could potentially lead Moderna to win EUA as early as this week.
• Last week, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) became the first vaccine candidate to win the EUA after the expert panel voted 17-4 with one abstention.
• https://seekingalpha.com/news/3645557-moderna-wins-adcom-backing-for-covidminus-19-vaccine